[1] |
Chow L Q M.Head and Neck Cancer[J].The New England Journal of Medicine, 2020, 382(1):60-72
|
[2] |
H S, J F, Rl S, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.[J].CA Cancer J Clin, 2021, 71(3):-
|
[3] |
Marur S, Forastiere A A.Head and Neck Squamous Cell Carcinoma: Update on Epidemiology,Diagnosis,and Treatment[J].Mayo Clinic Proceedings, 2016, 91(3):386-396
|
[4] |
Mody M D, Rocco J W, Yom S S, et al.Head and neck cancer[J].Lancet (London, England), 2021, 398(10318):2289-2299
|
[5] |
Field A, Adelman K.Evaluating Enhancer Function and Transcription[J].Annual Review of Biochemistry, 2020, 89:213-234
|
[6] |
Kim T-K, Hemberg M, Gray J M, et al.Widespread transcription at neuronal activity-regulated enhancers[J].Nature, 2010, 465(7295):182-187
|
[7] |
Chen H, Li C, Peng X, et al.A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples[J].Cell, 2018, 173(2):386-399
|
[8] |
Lee J-H, Xiong F, Li W.Enhancer RNAs in cancer: regulation,mechanisms and therapeutic potential[J].RNA biology, 2020, 17(11):1550-1559
|
[9] |
Arnold P R, Wells A D, Li X C.Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate[J].Frontiers in Cell and Developmental Biology, 2019, 7:377-
|
[10] |
Stasevich E M, Uvarova A N, Murashko M M, et al.Enhancer RNA AL928768[J].from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGHMYC Translocation. International Journal of Molecular Sciences, 2022, 23(9):4624-
|
[11] |
Huang Z, Yu H, Du G, et al.Enhancer RNA lnc-CES1-1 inhibits decidual cell migration by interacting with RNA-binding protein FUS and activating PPARγ in URPL[J].Molecular Therapy. Nucleic Acids, 2021, 24:104-112
|
[12] |
Pan C-W, Wen S, Chen L, et al.Functional roles of antisense enhancer RNA for promoting prostate cancer progression[J].Theranostics, 2021, 11(4):1780-1794
|
[13] |
Sahu D, Lin C-C, Goel A.Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer[J].Genes, 2023, 14(1):137-
|
[14] |
M Z, J Z, G L, et al.ELOVL2-AS1 inhibits migration of triple negative breast cancer.[J].PeerJ, 2022, 10:-
|
[15] |
Adhikary S, Roy S, Chacon J, et al.Implications of Enhancer Transcription and eRNAs in Cancer[J].Cancer Research, 2021, 81(16):4174-4182
|
[16] |
Zhang Z, Luo M, Li Q, et al.Genetic,Pharmacogenomic,and Immune Landscapes of Enhancer RNAs Across Human Cancers[J].Cancer Research, 2022, 82(5):785-790
|
[17] |
Gu X, Wang L, Boldrup L, et al.AP001056[J].A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck. Cancers, 2019, 11(3):347-
|
[18] |
Cai H, Liang J, Jiang Y, et al.Integrative Analysis of N6-Methyladenosine-Related Enhancer RNAs Identifies Distinct Prognosis and Tumor Immune Micro-Environment Patterns in Head and Neck Squamous Cell Carcinoma[J].Cancers, 2022, 14(19):4657-
|
[19] |
Shende N, Xu J, Li W T, et al.Enhancer RNA Profiling in Smoking and HPV Associated HNSCC Reveals Associations to Key Oncogenes[J].International Journal of Molecular Sciences, 2021, 22(22):12546-
|
[20] |
Diao P, Huang R, Shi Y, et al.Development of a novel prognostic signature derived from enhancer RNA-regulated genes in head neck squamous cell carcinoma[J].Head & Neck, 2023, 45(4):900-912
|
[21] |
Feng G, Wang T, Xue F, et al.Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma[J].Head & Neck, 2021, 43(12):3820-3831
|
[22] |
Shukla S, Evans J R, Malik R, et al.Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma[J].Journal of the National Cancer Institute, 2017, 109(1):d-j
|
[23] |
Yu L, Shen N, Shi Y, et al.Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data[J].Frontiers in Immunology, 2022, 13:1009789-
|
[24] |
Yan L, Wang J, Guo J, et al.Enhancer RNA IRS2e is essential for IRS2 expression and the oncogenic properties in oral squamous cell carcinoma[J].Carcinogenesis, 2023, 44(2):119-128
|
[25] |
Bi C, Cui H, Fan H, et al.LncRNA LINC01116 Promotes the Development of Colorectal Cancer by Targeting miR-9-5pSTMN1[J].OncoTargets and Therapy, 2020, 13:10547-10558
|
[26] |
Shao T-R, Zheng Z-N, Chen Y-C, et al.LncRNA AC007271[J].promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wntβ-catenin signaling pathway. Life Sciences, 2019, 239:117087-
|